Development of a new class of antibiotics gives hope for treating multi-drug resistant bacteria
New type of antibiotic could limit multidrug resistance by targeting and disrupting key elements in bacterial cells.
New type of antibiotic could limit multidrug resistance by targeting and disrupting key elements in bacterial cells.
Griffith University microbiologist Dr Kate Seib has been recognised for her distinguished contributions to microbiology research in Australia, including vaccine targets for diseases which cause meningitis, gonorrhoea and middle ear infections.
Dr Kate Seib has recently been awarded a NHMRC Career Development Fellowship for her research into bacteria-related disease which may lead to the development of vaccines.
Science will be on tap when researchers trade the lab for the pub.
Griffith University has been awarded nearly $1.4 million in National Health and Medical Research Council funding to develop new classes of antibiotics, further work around mosquito-borne viruses and improve outcomes for people with acute mental illness.
Griffith University's Institute for Glycomics has announced its 2016 research excellence awards.
GRIFFITH University has been named Employer of Choice for 2016 at the annual Women in Technology awards, building on its...
From scientific discoveries in Indonesia in human evolution to pounding the Gold Coast roads in the annual marathon, Griffith staff and students have been pushing the boundaries on many fronts
Barbara Hadley has been a professional snooker player, a private investigator and a chief toilet cleaner in the Greek Islands....
A team of Griffith University researchers has received more than $1 million to find new vaccine targets for diseases which cause meningitis, gonorrhoea and middle ear infections.